Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Survivor, caregiver, or friend? Share your brain tumor story and inspire others.
- Call our CareLine:
- 800-886-ABTA (2282)
Survivor, caregiver, or friend? Share your brain tumor story and inspire others.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Glioblastoma is one of the most aggressive and deadly forms of brain cancer, notorious for its resistance to treatment and devastating prognosis. But a breakthrough approach from the company Carthera is
This article is sponsored by Virginia Commonwealth University. Fear of cancer recurrence (FCR) is a commonly-reported phenomenon across cancer populations, but has largely been overlooked among those diagnosed with brain
TakeAim Lymphoma – Now Enrolling ** Sponsored by Curis. This content is not an endorsement from the ABTA.** Primary CNS Lymphoma (PCNSL) Curis is a biopharmaceutical company dedicated to developing
** Sponsored by Pacific Neuroscience Institute (PNI). This content is not an endorsement from the ABTA.** By Emmaline Mauitson, MPAP, PA-C James, 75, was vacationing in Hawaii with his wife
** Sponsored by Ono Pharmaceuticals. This content is not an endorsement from the ABTA.** In her job at a healthcare insurer, Barb Brady leads a team that collaborates with primary
**Sponsored by Plus Therapeutics. This content is not an endorsement from the ABTA.** ReSPECT-GBM Patient Story | Jim, Recurrent Glioblastoma Survivor Dr. Jim Stockand, a dedicated educator with a PhD
** Sponsored by Imvax. This content is not an endorsement from the ABTA.** Imvax is a pioneering clinical biotechnology company developing personalized cancer treatments specifically designed for glioblastoma (GBM) patients.
The NIH Clinical Center is the nation’s largest hospital devoted entirely to clinical research. Clinician-investigators translate scientific observations and laboratory discoveries into new approaches to diagnosing, treating, and preventing disease.
Always free for patients & caregivers
